Form 4: Axon CRO Brooks Reports XSU Vesting, Tax Withholding

Axon Enterprise's Chief Revenue Officer, Cameron Brooks, reported the vesting of performance-based restricted stock units and subsequent tax-related share disposition.

Summary

• Cameron Brooks, Axon's Chief Revenue Officer, reported transactions related to performance-based restricted stock units (XSUs) under the 2024 eXponential Stock Plan.
• Performance conditions for the first and second tranches of XSUs, originally granted on April 1, 2024, were certified by the Compensation Committee on August 28, 2025.
• The first tranche vested on October 1, 2025, leading to the acquisition of 31,620 shares of common stock.
• On October 31, 2025, 5,850 shares were disposed of at a price of $711.34 per share to cover tax liabilities associated with the vesting.
• Following these transactions, Brooks beneficially owns 44,468 shares of Axon common stock.
• The second tranche of XSUs is scheduled to vest on April 1, 2026, contingent upon continued employment.
• Vested shares are subject to a minimum holding period until the earlier of December 31, 2030, or the vesting date of a subsequent tranche, excluding shares withheld or sold for taxes.
• The Form 4 filing was submitted late due to an administrative error.

Sentiment

Score: 7

Explanation: The filing indicates the successful achievement of performance targets for executive compensation, which is a positive sign for company performance. The late filing due to an administrative error is a minor negative compliance aspect. Overall, the event is routine and generally positive for the executive and reflects positively on the company's performance metrics.

Positives

• Performance conditions for two tranches of performance-based restricted stock units were successfully met and certified by the Compensation Committee.
• The vesting of 31,620 shares indicates the achievement of company performance targets, aligning executive incentives with shareholder value.

Negatives

• The Form 4 filing was submitted late due to an administrative error, which represents a minor compliance issue.

Risks

• The vesting of the second tranche of XSUs on April 1, 2026, is contingent upon continued employment, posing a risk to the reporting person if employment ceases before that date.
• Vested shares are subject to a minimum holding period until December 31, 2030, or the vesting of a subsequent tranche, which limits the immediate liquidity for the reporting person.

Future Outlook

The second tranche of performance-based restricted stock units is scheduled to vest on April 1, 2026, contingent upon continued employment. Vested shares are subject to a minimum holding period until December 31, 2030, or the vesting of a subsequent tranche.

Industry Context

This Form 4 filing reflects routine executive compensation practices involving performance-based equity awards, which are common across many publicly traded technology and defense companies. Such awards are designed to align executive incentives with long-term company performance and shareholder value.

Stakeholder Impact

• Shareholders: The vesting of performance-based units suggests that company performance targets, which are designed to benefit shareholders, have been met. The disposition for tax purposes is a routine event and does not significantly impact the broader share structure.
• Employees (specifically Cameron Brooks): The vesting represents a significant compensation event, aligning the Chief Revenue Officer's interests with company performance and providing a substantial equity award.

Next Steps

• The second tranche of performance-based restricted stock units is expected to vest on April 1, 2026, subject to continued employment.
• The reporting person will continue to hold vested shares subject to the specified minimum holding period.

Key Dates

Keywords

Axon Enterprise, AXON, Cameron Brooks, Chief Revenue Officer, Form 4, Insider Trading, Restricted Stock Units, RSU Vesting, Performance Shares, Executive Compensation, Share Disposition, Tax Withholding